Taxane induced peripheral neuropathy (TIPN) is an important survivorship issue for many cancer patients. Currently, there are no clinically implemented biomarkers to predict which patients might be at increased risk for TIPN.

READ FULL ARTICLE Curated publisher From clincancerres.aacrjournals.org